申请人:Boehringer Ingelheim International GmbH
公开号:EP2418207A1
公开(公告)日:2012-02-15
Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
揭示了调节CB2受体的化合物。根据本发明的化合物结合并是CB2受体的激动剂,可用于治疗炎症。那些是激动剂的化合物还可用于治疗疼痛。